Titan Bioscience Profile
Key Indicators
- Authorised Capital ₹ 2.49 M
as on 16-11-2024
- Paid Up Capital ₹ 2.49 M
as on 16-11-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -28.19%
(FY 2023)
- Profit -4.23%
(FY 2023)
- Ebitda -57.73%
(FY 2023)
- Net Worth -3.13%
(FY 2023)
- Total Assets -5.69%
(FY 2023)
About Titan Bioscience
The Corporate was formerly known as Subhrek Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.49 M and a paid-up capital of Rs 2.49 M, as per Ministry of Corporate Affairs (MCA) records.
Yatra Shah, Himanshu Parmar, and Kamlesh Shah serve as directors at the Company.
- CIN/LLPIN
U24239GJ2008PTC052906
- Company No.
052906
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Titan Bioscience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Parmar  | Director | 24-Jan-2022 | Current |
| Yatra Shah | Director | 24-Jun-2022 | Current |
| Kamlesh Shah | Director | 13-Feb-2008 | Current |
Financial Performance of Titan Bioscience.
Titan Bioscience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 28.19% decrease. The company also saw a slight decrease in profitability, with a 4.23% decrease in profit. The company's net worth dipped by a decrease of 3.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Titan Bioscience?
In 2023, Titan Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Titan Bioscience?
Titan Bioscience has a workforce of 3 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Titan Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Titan Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
